The goal of this clinical trial is to learn about the effects of consuming fermented pulses (certain types of legumes like chickpeas or lentils) in healthy people. The main questions it aims to answer are: 1. How does consuming the fermented foods impact the gut microbiome? 2. Does this interaction between the fermented foods and the gut microbiome affect inflammation? Participants will be asked to consume two sets of prepared meals, one containing unfermented pulses, the other containing fermented pulses. Researchers will compare the gut microbiome and inflammation between these two diets.
The rationale for the research is that fermentation of pulses can reduce the concentration of compounds that suppress butyrate producing bacteria and butyrate production. This will in turn boost butyrate production during consumption of these fermented pulses relative to that in unfermented pulses. This in turn will lead to lower inflammation in people consuming fermented pulses. To best study this question the investigators will utilize a cross-over design trial where participants will consume daily meals containing either fermented or unfermented pulses (chickpeas), followed by a washout period and then a period of consuming the other type of pulse. The investigators hypothesize that those consuming the fermented pulses will experience a significant decrease in inflammatory markers driven by increased butyrate production by gut bacteria.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
30
Frozen meals containing 100 g unfermented chickpeas
Frozen meals containing 100 g fermented chickpeas
Change in inflammation levels from baseline and between interventions
Measured in blood (IL-1β, IL-6, IL-10, IL-12, IFN-γ, TNF-α) and in feces (NGAL, calprotectin)
Time frame: At 2 weeks (baseline), 4 weeks (after first intervention), 8 weeks (after second intervention)
Change in fecal short chain fatty acids from baseline and between interventions
Measurement of acetate, propionate and butyrate in feces
Time frame: At 2 weeks (baseline), 4 weeks (after first intervention), 8 weeks (after second intervention)
Change in gut microbiome composition from baseline and between interventions
Measured by fecal 16S rRNA gene sequencing
Time frame: At 2 weeks (baseline), 4 weeks (after first intervention), 8 weeks (after second intervention)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.